ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2025
Elevated Resting Heart Rate Is an Independent Risk Factor for Mortality in Patients with Colorectal Cancer: A Retrospective Cohort Study.
Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Markers of Autonomic Function and Cancer Mortality Risk in Healthy Adults.JACC. Advances · 2026Article
- Prognostic role of resting heart rate in patients with colorectal cancer.Journal of gastrointestinal oncology · 2026Article
- Preoperative resting heart rate and colorectal cancer mortality: a robust association, but causality remains unestablished.Journal of gastrointestinal oncology · 2026Article
Corrections and comments
- Commented on by
Authors and funding
12 authors.
Funding
Abstract
backgroundAlthough lifestyle factors are associated with resting heart rate (RHR), its association with mortality in patients with colorectal cancer has not been fully understood. Therefore, we sought to determine whether RHR is associated with all-cause and colorectal cancer-specific mortality in patients with stage I to III colorectal cancer.
methodsWe included a total of 3,631 patients from the Severance Hospital Colorectal Cancer Registry (Seoul, South Korea) who underwent surgery for stage I to III colorectal cancer. RHR data were collected on the day of surgery. We utilized multivariable Cox proportional hazards models to estimate HRs and 95% confidence intervals (CI) for the association between RHR and all-cause and colorectal cancer-specific mortality.
resultsDuring a median follow-up of 3.0 years, there were 292 all-cause and 177 colorectal cancer-specific deaths. Patients in the highest quintile of RHR [≥88 beats per minute (bpm)] versus patients in the lowest quintile of RHR (≤66 bpm) showed a 3.33-fold increased risk of all-cause mortality (95% CI, 1.85-5.99) and a 2.98-fold increased risk of colorectal cancer-specific mortality (95% CI, 1.72-5.16). For every 10-bpm increase in RHR, there was a 1.44-fold increase in all-cause mortality (95% CI, 1.32-1.58) and a 1.50-fold increase in colorectal cancer-specific mortality (95% CI, 1.33-1.69).
conclusionsElevated RHR on the day of surgery for colorectal cancer is associated with a higher risk of all-cause/colorectal cancer-specific mortality. IMPACT: Our data suggest that RHR may serve as a clinically relevant predictor of mortality in patients who undergo surgery for colorectal cancer.
Indexed as
Identifiers
40960855What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.